NEW YORK--BioInform is pleased to introduce a new regular feature, the BioInform Genomics Index, which charts the market capitalization of 32 companies that are publicly traded in the US and whose major business focus is bioinformatics and genomics. To be included, companies had to have market capitalization of at least $50 million as of June 1, 1998, the day we started tracking the index. The total market value of the companies on that date has been indexed to 100; therefore, the index charts the percentage change in the companies' aggregate value since then.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.